Hope S. Rugo, MD, FASCO
Professor of Medicine, Director, Breast Oncology And Clinical Trials Education Helen Diller Family Comprehensive Cancer Center, University Of California, San Francisco, CA, USA
Hope S. Rugo, MD, FASCO, is Professor of Medicine and Director of Breast Oncology and Clinical Trials Education at the University of California, San Francisco (UCSF), at the Helen Diller Family Comprehensive Cancer Center. She received her medical degree from the University Of Pennsylvania School Of Medicine before completing a residency in Internal Medicine followed by a fellowship in Hematology and Oncology at UCSF. Dr. Rugo also completed a postdoctoral fellowship in Immunology at Stanford University. Dr. Rugo is a principal investigator for multiple clinical trials focused on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer. Her current research interests include immunotherapy and combinations of targeted agents in the treatment of breast cancer to overcome resistance as well as evaluation and management of toxicity. She is chair of the Safety Committee for the multicenter randomized phase II I-SPY2 trial, and co-chair of the Triple Negative Working Group of the Translational Breast Cancer Research Consortium (TBCRC). Dr. Rugo has been recognized for her excellence in patient care, teaching medical students, and training physicians. She is a frequently invited lecturer locally, nationally, and internationally on subjects relating to the treatment of and supportive care for breast cancer.